Literature DB >> 15761095

Disability-induced identity changes in persons with multiple chemical sensitivity.

Pamela Reed Gibson1, Elizabeth Placek, Jennifer Lane, Sacha Ostroff Brohimer, Amy C Earehart Lovelace.   

Abstract

In this qualitative study, the authors asked respondents with multiple chemical sensitivity (MCS) in an open-ended question how having the condition affected their identities. Authors then examined responses for themes, which they discuss within the framework of critical theory. Emergent themes included loss of a stable, familiar personality, loss of self-positioning, emotional suppression to meet others' expectations, redesigning the planned life, forced growth, struggling with support, discovering the spiritual self, and identity reconsolidation. The authors compare findings with published works on adjustment to chronic illness and other delegitimized illnesses, find them to be fairly congruent, and then discuss problems regarding cultural acceptance of MCS as a condition caused by chemical exposure.

Entities:  

Mesh:

Year:  2005        PMID: 15761095     DOI: 10.1177/1049732304271960

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  3 in total

1.  Out of Chaos-Meaning Arises: The Lived Experience of Re-Habituating the Habitual Body When Suffering From Burnout.

Authors:  Karin Mohn Engebretsen; Wenche Schrøder Bjorbækmo
Journal:  Qual Health Res       Date:  2020-05-04

2.  A study of two generic health-related quality of life questionnaires--Nottingham Health Profile and Short-Form 36 Health Survey--and of coping in patients with sensory hyperreactivity.

Authors:  Marja-Leena Kristofferzon; Ewa Ternesten-Hasséus
Journal:  Health Qual Life Outcomes       Date:  2013-10-29       Impact factor: 3.186

3.  From individual coping strategies to illness codification: the reflection of gender in social science research on multiple chemical sensitivities (MCS).

Authors:  Geneviève Nadeau; Katherine Lippel
Journal:  Int J Equity Health       Date:  2014-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.